Agilent completes Proscia acquisition for up to $270m
Agilent has completed its acquisition of digital pathology software provider Proscia for up to $270 million. The company aims to support AI-assisted pathology workflows, companion diagnostics development and drug discovery.
Who is affected and how
- medtech company
- Digital pathology is consolidating, with laboratory and diagnostics players integrating AI into their platforms.
- pharmaceuticals
- AI-based pathology data is playing a growing role in companion diagnostics development.
Sources
- Agilent Completes Proscia Acquisition for Up to $270M, Expanding AI-Powered Digital Pathology Capabilities | citybizcitybiz.co · Nov 4, 2026
- Agilent completes $240M Proscia digital pathology dealrdworldonline.com · Nov 4, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.